Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Pennsylvania for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Pennsylvania only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Pennsylvania (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Daniel Shrager (NPI 1396784120)

Field	Value
Entity Type	Individual
Organization	Daniel Shrager
Address	670 Lawn Ave
City	Sellersville
State	PA
ZIP	18960
Taxonomy	Dermatology Physician
NPI Enumerated	June 6, 2006

Payer Source	Total Paid
Medicare	$3.4M
Medicaid	$0

Key Findings

This provider’s billing is effectively single‑payer: total Medicare revenue is $3.4M and there is no Medicaid billing on file, indicating Medicare accounts for virtually all reported public‑program activity. Analysts should treat this profile as Medicare‑centric when evaluating payer mix or access implications.

Revenue is highly concentrated in a very small set of Medicare codes: the top 3 Medicare codes by revenue (J3245, 77280, 0394T) account for 77.8% of the provider’s total Medicare revenue, signaling a narrow set of high‑value services driving the practice’s public‑payer cash flow. Detailed review of reimbursement, utilization controls, and clinical documentation for those codes is warranted because they dominate payments.

J3245 is the single largest revenue driver at $1.9M (57.4% of Medicare revenue) and the provider ranks #2 of 225 nationally for this code (100th percentile; extreme outlier). This positioning identifies the practice as a national outlier for tildrakizumab injections and suggests biologic injectable therapy for dermatologic disease is a core service line.

77280 contributes $353.7K (10.7% of Medicare revenue) and the provider ranks #52 of 3348 nationally (98th percentile; extreme outlier). Because 77280 describes simulation/imaging for radiation therapy ports, this unusually high-volume billing for a dermatology‑taxonomized provider points to substantial revenue from radiation‑planning services or arrangements to bill such services; it merits operational review given its atypical presence in a dermatology physician profile.

0394T accounts for $317.3K (9.6% of Medicare revenue) and the provider ranks #6 of 75 nationally (93th percentile; typical, unremarkable volume); the dataset includes no description for 0394T. Despite the missing description, the code’s place in the top three revenue drivers makes it important to investigate further to understand the clinical and billing context fueling nearly one‑tenth of Medicare revenue.

Beyond the top three, the provider shows consistently elevated volumes for core dermatology procedures and office visits: examples include 11102 at $126.1K (3.8%) ranked #19 of 18797 (100th percentile; extreme outlier), 99212 at $108.3K (3.3%) ranked #15 of 99011 (100th percentile; extreme outlier), and multiple lesion destruction and biopsy add‑on codes flagged as notably above typical or extreme outliers. This mix indicates high procedural throughput for biopsies, lesion destruction, and frequent low‑complexity office visits, consistent with a high‑volume dermatologic practice model.

The provider’s competitive standing is mixed by service line: they are a dominant national outlier for several high‑revenue codes (notably J3245 and other biopsy/E&M codes), while surgical repair and reconstructive codes (for example 14020 at $42.6K ranked #30 of 268, 14040 at $36.9K ranked #141 of 1131) fall into more typical percentiles. This pattern suggests market leadership in medical dermatology and injectable therapeutics, with surgical services present but not the primary national differentiator.

The NPI enumeration date of 2006-06-06 (~20 years ago) indicates a long tenure in the Medicare program, which combined with persistent outlier volumes on multiple codes suggests these billing patterns are enduring rather than transient. For payers and contracting analysts, the longevity plus concentrated code mix supports targeted audits of service documentation, capacity planning for biologic administration, and consideration of value‑based contracting approaches aligned to the provider’s dominant service lines.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

46 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3245	Injection, tildrakizumab, 1 mg	17,200	$110	$1.9M
77280	The provider uses a simulator or other imaging modality to determine the size and location of ports to be used for radiation therapy. This code describes a simple level service.	1,530	$230	$353.7K
0394T	N/A	1,530	$210	$317.3K
11102	The provider biopsies a single skin lesion using a tangential (side–ways) approach; he shaves off the lesion or scoops it out with a knife or curette.	1,910	$70	$126.1K
99212	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,…	2,640	$40	$108.3K
17110	The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of one to 14 lesions other than skin tags or…	820	$80	$67.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	970	$70	$65.1K
17000	The provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of the first or only lesion.	1,790	$40	$64.5K
11103	The provider biopsies an additional skin lesion using a tangential (side–ways) approach; he shaves off the lesion or scoops it out with a knife or curette. Report +11103 for each separate lesion…	1,050	$40	$44K
14020	The provider repairs the defects in the patient’s scalp, arms, and/or legs by using healthy tissues from an adjacent site. This code represents services for defects of 10 cm2 or less.	70	$600	$42.6K

Showing 1–10 of 46

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 46 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Pennsylvania Distribution

Daniel Shrager — 13 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Pennsylvania

Full comparison — all codes billed, vs. state median

46 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	1	10	3,750	$110	$670.1K
0394T	1	10	1,080	$210	$221.6K
14020	4	20	40	$530	$32.5K
14040	8	40	20	$570	$27K
14060	42	90	20	$580	$20.9K
13132	110	110	60	$200	$18.8K
14000	7	10	30	$470	$16.8K
99214	10,908	23,230	100	$80	$14.5K
13121	82	120	30	$230	$12K
21930	1	10	30	$430	$11.5K

Showing 1–10 of 46

Related Providers

Other providers that share a Tax Identification Number (TIN) with Daniel Shrager, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Daniel Shurman	PA	Dermatology Physician	$2.9M	$38.5K
Aerlyn Dawn	PA	Dermatology Physician	$1.2M	$0
Dorota Wilson	PA	Dermatology Physician	$1M	$0
Jennifer Larusso	NJ	MOHS-Micrographic Surgery Physician	$885K	$0
Firas Hougeir	GA	Dermatology Physician	$689.7K	$0
Imran Amir	PA	Dermatology Physician	$689.1K	$0
Richard Cordova	PA	Dermatology Physician	$559.9K	$11.1K
Leonid Izikson	NY	Dermatology Physician	$303.5K	$4K
Minh Thieu	PA	Dermatology Physician	$299.7K	$0

Nearby Providers

Other providers in the same ZIP code as Daniel Shrager, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bayada Home Health Care, Inc.	PA	Home Health Agency	$0	$19.6M
Penn Foundation Inc	PA	Community/Behavioral Health Agency	$0	$8.3M
Penn Foundation, Inc.	PA	Community/Behavioral Health Agency	$0	$6.1M
Leo Santamarina	PA	Ophthalmology Physician	$2.4M	$0
James Spears	PA	Hematology & Oncology Physician	$2.1M	$0
Sarah Goodyear	PA	Hematology & Oncology Physician	$1.6M	$0
Mitchell Alden	PA	Hematology & Oncology Physician	$1.5M	$0
Anthony Magdalinski	PA	Hematology & Oncology Physician	$1.3M	$0
Martin Hightower	PA	Radiation Oncology Physician	$961.4K	$0
The Endoscopy Center LLC	PA	Clinic/Center	$886.5K	$3.8K

Daniel Shrager — Billing Profile & Reimbursement Data

Sign up for Daniel Shrager — Billing Profile & Reimbursement Data policy alerts

Daniel Shrager — Billing Profile & Reimbursement Data

Sign up for Daniel Shrager — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References